Tarsus Pharmaceuticals (TARS) Earnings Date & Reports
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TARS is expected to report earnings to rise 232.56% to -142 cents per share on November 03
Q3'26
Est.
$-1.43
Q2'26
Missed
by $0.21
Q1'26
Beat
by $0.14
Q4'25
Missed
by $0.12
Q3'25
Beat
by $0.05
The last earnings report on August 06 showed earnings per share of -43 cents, missing the estimate of -21 cents. With 207.55K shares outstanding, the current market capitalization sits at 3.28B.